Page (1) of 1 - 02/14/18
Amgen Announces FDA Advisory Committee Meeting To Review Potential New Use Of BLINCYTO® (blinatumomab)
First-Ever Application to be Submitted for an MRD Positive Indication
February 14, 2018 --
This article is no longer available,but here are some related topics.
Manufacturing,Sales,Applications,Suppliers,Manufacturing/Production,Marketing,Insurance,Shipping & Receiving,Manufacturing,Sales & Marketing,Security,Business Issues,Administration,Legal,Sales,Sales,USA,IT (Information Technology),Security,Medicine,Disease,healthcare,Cancer,Therapy,Technology,
All Rights Reserved